Illustratively, luteolin‐treated sensitive cells release exosomes that enhance the chemosensitivity of adriamycin‐resistant cancer cells through miR‐384 upregulation and subsequent suppression of the PTN‐β‐catenin‐MDR1 signaling cascade. This evidence concerns the gene PTN and cancer.